June 2, 2008 - GE Healthcare will showcase its molecular imaging technologies such as the IN Cell Analyzer and Positron Emission Tomography/Volume Computer Assisted Reading (PET-VCAR) at ASCO 2008, which wraps up today in Chicago.
Linking discovery and research with clinical oncology, GE Healthcare’s IN Cell Analyzer System from its Life Science Division, represents a reportedly complete solution for high-content sub-cellular analysis. Used in research and drug discovery, the system performs assays directly inside cells and uses sophisticated image analysis techniques to give quantitative results for those assays for each individual cell. The power of the IN Cell Analyzer comes from using the high throughput it delivers to analyze thousands of cells under different conditions to generate statistically robust data, said the company.
Also on display is GE’s PET-VCAR, a system designed to help optimize tumor management by enabling early quantification and evaluation of treatment effectiveness. It features workflow enhancements for both single and multi-exam review, and includes exam-to-exam auto-registration, tumor segmentation and quantification and multi-planar image review. PET VCAR aims to make PET/CT images more useful for clinicians, said the company.
For more information: www.gehealthcare.com